recommended for detection of TRAFD1 of human origin by WB, IP, IF, IHC(P) and ELISA
Modification Notes
TRAFD1 (TRAF-type zinc finger domain containing 1), also known as FLN29, is a novel 582 amino acid protein that acts as a lipopolysaccharide (LPS)- and interferon (IFN)-inducible negative regulator, and may also play a role in endotoxin tolerance. TRAFD1 also interacts with TRAF6 to negatively regulate toll-like receptor (TLR) signaling. TRAFD1 contains one TRAF-type zinc finger and contains multiple phosphoserine and phosphothreonine residues. The gene encoding TRAFD1 maps to human chromosome 12, which encodes over 1,100 genes and comprises approximately 4.5% of the human genome. Chromosome 12 is associated with a variety of diseases and afflictions, including hypochondrogenesis, achondrogenesis, Kniest dysplasia, Noonan syndrome and trisomy 12p, which causes facial developmental defects and seizure disorders.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFIHCELISA
WB:1:500~1:2000 IP:1:100~1:500 IF:1:200~1:500 IHC:1:50~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher.
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
recommended for detection of TRAFD1 of human origin by WB IP IF IHC(P) and ELISA
Tissue Specificity
recommended for detection of TRAFD1 of human origin by WB, IP, IF, IHC(P) and ELISA